ArticleInternational journal of nanomedicine2025
Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson's Disease Targeting α-Synuclein.
Luca Casula et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.